Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
STAR Protocols|February 27, 2025
Protocol for purifying biologically active microtubule-severing protein UNC-45A from E.coli using GST-affinity and spin columnsAsumi Hoshino, Nimisha Krishnan, Mihir Shetty, et al.The Journal of Biological Chemistry|October 20, 2023
The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of TaxolAsumi Hoshino, Valentino Clemente, Mihir Shetty, et al.Biorxiv : the Preprint Server for Biology|September 25, 2023
The Microtubule Severing Protein UNC-45A Counteracts the Microtubule Straightening Effects of TaxolAsumi Hoshino, Valentino Clemente, Mihir Shetty, et al.International Journal of Molecular Sciences|January 11, 2019
Targeting Mitochondria for Treatment of Chemoresistant Ovarian CancerEdith Emmings, Sally Mullany, Zenas Chang, et al.Journal of Visualized Experiments : Jove|May 21, 2015
Method for measuring the activity of deubiquitinating enzymes in cell lines and tissue samplesPercy Griffin, Ashley Sexton, Lauren Macneill, et al.Cells|July 2, 2021
UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous SystemValentino Clemente, Asumi Hoshino, Joyce Meints, et al.Molecular Therapy. Oncology|June 17, 2025
Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based toolsMorgann Madill, Arpit Aggarwal, Anant Madabhushi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatmentZhenhua Lin, Martina Bazzaro, Mei-Cheng Wang, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome PredictionEmil Lou, Valentino Clemente, Marcel Grube, et al.Plos One|December 11, 2012
Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumorsThanasak Sueblinvong, Rahel Ghebre, Yoshie Iizuka, et al.Pageof 5